Jeffrey Epstein Hoped to Seed Human Race With His DNA
By James B. Stewart, Matthew Goldstein, and Jessica Silver-Greenberg,
The New York Times
| 07. 31. 2019
Over the years, Jeffrey Epstein surrounded himself with many prominent scientists, including several affiliated with Harvard.
Jeffrey E. Epstein, the wealthy financier who is accused of sex trafficking, had an unusual dream: He hoped to seed the human race with his DNA by impregnating women at his vast New Mexico ranch.
Mr. Epstein over the years confided to scientists and others about his scheme, according to four people familiar with his thinking, although there is no evidence that it ever came to fruition.
Mr. Epstein’s vision reflected his longstanding fascination with what has become known as transhumanism: the science of improving the human population through technologies like genetic engineering and artificial intelligence. Critics have likened transhumanism to a modern-day version of eugenics, the discredited field of improving the human race through controlled breeding.
Mr. Epstein, who was charged in July with the sexual trafficking of girls as young as 14, was a serial illusionist: He lied about the identities of his clients, his wealth, his financial prowess, his personal achievements. But he managed to use connections and charisma to cultivate valuable relationships with business and political leaders.
Interviews with more than a dozen of...
Related Articles
By Staff [cites CGS' Katie Hasson], Radio New Zealand | 04.05.2025
At a time where some countries are struggling with low birth rates, the voices for pronatalism are getting louder. But it’s who’s sounding the call for more babies that has people talking.
Tech giant Elon Musk has fourteen children and...
By Amanda Hess, The New York Times | 04.05.2025
Image "Elon Musk" by Debbie Rowe on Wikimedia Commons licensed under CC by S.A. 3.0
For months, an internet-wide guessing game has swirled around the question of where Elon Musk’s intelligence falls on the bell curve. President Trump has called...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...